ID   CNMD_RAT                Reviewed;         334 AA.
AC   O70367;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   24-JAN-2024, entry version 112.
DE   RecName: Full=Leukocyte cell-derived chemotaxin 1 {ECO:0000305};
DE   AltName: Full=Chondromodulin {ECO:0000312|RGD:620176};
DE   Contains:
DE     RecName: Full=Chondrosurfactant protein;
DE              Short=CH-SP;
DE   Contains:
DE     RecName: Full=Chondromodulin-1;
DE     AltName: Full=Chondromodulin-I;
DE              Short=ChM-I;
DE   Flags: Precursor;
GN   Name=Cnmd {ECO:0000312|RGD:620176};
GN   Synonyms=Chmi {ECO:0000312|RGD:620176}, Lect1 {ECO:0000312|RGD:620176};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar Kyoto; TISSUE=Cartilage;
RX   PubMed=11328727;
RA   Funaki H., Sawaguchi S., Yaoeda K., Koyama Y., Yaoita E., Funaki S.,
RA   Shirakashi M., Oshima Y., Shukunami C., Hiraki Y., Abe H., Yamamoto T.;
RT   "Expression and localization of angiogenic inhibitory factor,
RT   chondromodulin-I, in adult rat eye.";
RL   Invest. Ophthalmol. Vis. Sci. 42:1193-1200(2001).
RN   [2]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16980969; DOI=10.1038/nm1476;
RA   Yoshioka M., Yuasa S., Matsumura K., Kimura K., Shiomi T., Kimura N.,
RA   Shukunami C., Okada Y., Mukai M., Shin H., Yozu R., Sata M., Ogawa S.,
RA   Hiraki Y., Fukuda K.;
RT   "Chondromodulin-I maintains cardiac valvular function by preventing
RT   angiogenesis.";
RL   Nat. Med. 12:1151-1159(2006).
CC   -!- FUNCTION: Bifunctional growth regulator that stimulates the growth of
CC       cultured chondrocytes in the presence of basic fibroblast growth factor
CC       (FGF) but inhibits the growth of cultured vascular endothelial cells.
CC       May contribute to the rapid growth of cartilage and vascular invasion
CC       prior to the replacement of cartilage by bone during endochondral bone
CC       development. Inhibits in vitro tube formation and mobilization of
CC       endothelial cells. Plays a role as antiangiogenic factor in cardiac
CC       valves to suppress neovascularization (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Chondromodulin-1]: Secreted, extracellular
CC       space, extracellular matrix {ECO:0000250}. Note=Accumulated in the
CC       inter-territorial matrix of cartilage. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Chondrosurfactant protein]: Endomembrane system
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in cartilage, cardiac valves and valvular
CC       interstitial cells (at protein level). Expressed in eye.
CC       {ECO:0000269|PubMed:16980969}.
CC   -!- DEVELOPMENTAL STAGE: Expression first detected in heart at 9.5 dpc and
CC       persisted in the adult. {ECO:0000269|PubMed:16980969}.
CC   -!- PTM: After cleavage, the post-translationally modified ChM-I is
CC       secreted as a glycoprotein. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chondromodulin-1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF051425; AAC05574.1; -; mRNA.
DR   RefSeq; NP_110481.1; NM_030854.1.
DR   AlphaFoldDB; O70367; -.
DR   STRING; 10116.ENSRNOP00000017400; -.
DR   GlyCosmos; O70367; 1 site, No reported glycans.
DR   GlyGen; O70367; 1 site.
DR   PhosphoSitePlus; O70367; -.
DR   PaxDb; 10116-ENSRNOP00000017400; -.
DR   GeneID; 81512; -.
DR   KEGG; rno:81512; -.
DR   UCSC; RGD:620176; rat.
DR   AGR; RGD:620176; -.
DR   CTD; 11061; -.
DR   RGD; 620176; Cnmd.
DR   eggNOG; ENOG502QVPC; Eukaryota.
DR   InParanoid; O70367; -.
DR   OrthoDB; 5342368at2759; -.
DR   PhylomeDB; O70367; -.
DR   PRO; PR:O70367; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0051216; P:cartilage development; IEA:UniProtKB-KW.
DR   GO; GO:0001886; P:endothelial cell morphogenesis; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   Gene3D; 3.30.390.150; -; 1.
DR   InterPro; IPR007084; BRICHOS_dom.
DR   InterPro; IPR043405; Chondromodulin/Tenomodulin.
DR   PANTHER; PTHR14064; CHONDROMODULIN-RELATED; 1.
DR   PANTHER; PTHR14064:SF6; LEUKOCYTE CELL-DERIVED CHEMOTAXIN 1; 1.
DR   Pfam; PF04089; BRICHOS; 1.
DR   SMART; SM01039; BRICHOS; 1.
DR   PROSITE; PS50869; BRICHOS; 1.
PE   1: Evidence at protein level;
KW   Chondrogenesis; Cleavage on pair of basic residues; Developmental protein;
KW   Differentiation; Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Membrane; Reference proteome; Secreted; Transmembrane; Transmembrane helix.
FT   CHAIN           1..210
FT                   /note="Chondrosurfactant protein"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000005352"
FT   PROPEP          211..214
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000005353"
FT   CHAIN           215..334
FT                   /note="Chondromodulin-1"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000005354"
FT   TRANSMEM        46..66
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          105..201
FT                   /note="BRICHOS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00255"
FT   REGION          212..268
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        243
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        132..193
FT                   /evidence="ECO:0000250"
FT   DISULFID        282..286
FT                   /evidence="ECO:0000250"
FT   DISULFID        283..323
FT                   /evidence="ECO:0000250"
FT   DISULFID        293..317
FT                   /evidence="ECO:0000250"
FT   DISULFID        297..313
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   334 AA;  37387 MW;  DB865E515952A4CD CRC64;
     MTENSDKVPI TMVGPEDVEF CSPPAYATVT VKPSGSPTRL LKVGAVVLIS GAVLLLFGAI
     GAFYFWKGND NHIYNVHYTM SINGRLQDAS MEIDAANNLE TFKMGSGAEE AIEVNDFQNG
     ITGIRFAGGE KCYIKAQVKA RIPEVSTGTK QSISELEGKI MPVKYEENSL IWVAVDQPVK
     DNSFLSSKIL EFCGDLPIFW LKPMYPKEIP RERREVVRSS APSTTRRPHS EPRGNAGPGR
     LSNRTRPSVQ DDEEPFNPDN PYHQQEGESM TFDPRLDHEG ICCIECRRSY THCQKICEPL
     GGYYPWPYNY QGCRSACRVV MPCSWWVARI LGMV
//
